ESR
2.7.1.3. The specific considerations of procurement of medications and medical devices necessitated by the pandemic or carried out during the pandemic are established in such a way as to prevent corruption risks
Problem solving:
2.7.1. Patients and doctors do not receive medications and medical devices in a timely manner and in full, in particular due to the incomplete transition to the new system of organization and control of medical procurement, and the incomplete regulation of the processes of identifying the needs for and accounting of medications
Deadlines for all measures within ESR
01.03.2023 -
31.10.2023
Implementation of SACP measures within ESR
Total number of measures –
5
4
1
Implemented
Partially implemented
Implementation of SACP measures within the scope of the Problem by main main performers
Ministry of Health of Ukraine
100%
5
Summarized general information on Measures
Indicators of achievement of ESR
Total number of indicators – 2
Indicators fully achieved – 0
Partially achieved indicators – 0
Indicators with a score of 0% – 2
Summarized general information about Achievement Indicators
№ | Indicators | Weight (%) |
---|---|---|
1 | An analytical report has been published on the findings of the analytical study on the assessment of corruption risks in the procurement of medications and medical devices necessitated by the pandemic or conducted during the pandemic, with the presentation of proposals on how to prevent the identified corruption risks and to enhance the transparency and effectiveness of the procurement procedures. | 90% |
2 | Amendments to normative legal acts have come into force, which pertain to the specific considerations of procurement of medications and medical devices necessitated by the pandemic or carried out during the pandemic, taking into account the findings of the analytical study indicated in subclause 1 of clause 2.7.1.3. | 10% |